(Q35056873)

English

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

0 references

1 reference

based on heuristic

inferred from title

Francesca Ceccherini-Silberstein

7

object named as

Francesca Ceccherini-Silberstein

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Alessandro Cozzi-Lepri

1

object named as

Alessandro Cozzi-Lepri

0 references

Antonella d'Arminio Monforte

8

object named as

Antonella D'Arminio Monforte

0 references

5

object named as

Martin Däumer

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Marc Noguera-Julian

2

object named as

Marc Noguera-Julian

0 references

Francesca Di Giallonardo

3

object named as

Francesca Di Giallonardo

0 references

Karin J Metzner

object named as

Karin J Metzner

23

0 references

object named as

Roger D Kouyos

16

0 references

Huldrych F Günthard

object named as

Huldrych F Günthard

20

0 references

Hansjakob Furrer

18

object named as

Hansjakob Furrer

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Bernard Masquelier

14

object named as

Bernard Masquelier

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

22

object named as

Roger Paredes

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Françoise Brun-Vézinet

21

object named as

Francoise Brun-Vezinet

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

11

object named as

Rolf Kaiser

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Rob Schuurman

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sue Aitken

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Anna Maria Geretti

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Clare L Booth

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Claudia Michalik

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Klaus Jansen

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Pantxika Bellecave

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Erika Castro

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Anna Schultze

19

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

CHAIN Minority HIV-1 Variants Working Group

24

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

21 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

930-940

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

17 January 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Next-generation sequencing of HIV-1 RNA genomes: determination of error rates and minimizing artificial recombination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

The prevalence of transmitted resistance to first-generation non-nucleoside reverse transcriptase inhibitors and its potential economic impact in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Persistence of HIV-1 transmitted drug resistance mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Update of the drug resistance mutations in HIV-1: March 2013.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Estimating Frequencies of Minority Nevirapine-Resistant Strains in Chronically HIV-1-Infected Individuals Naïve to Nevirapine by Using Stochastic Simulations and a Mathematical Model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Basic concepts in RNA virus evolution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

8 July 2018

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU426

21 January 2018

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU426

21 January 2018

Case-control studies: basic concepts.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU426

21 January 2018

Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU426

21 January 2018

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU426

21 January 2018

E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU426

21 January 2018

Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU426

21 January 2018

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4319483

25 October 2018

Identifiers

10.1093/JAC/DKU426

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35056873&oldid=1859956621"